In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...